Dashboard
Financial statements
A

Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025
Revenue FY2025
$6.9B
3y CAGR +0.5% P18
Net income FY2025
$1.3B
Net margin +18.8% P76
Total assets FY2025
$12.7B
ROA +10.2% P73
Operating cash flow FY2025
$1.6B
FCF margin +16.6% P57
19 yrs · FY2007–FY2025 9 filed · 0 derived · 0 blank

Year-over-year change per cell; first column has no prior.

Balance Sheet

Assets, liabilities, and equity

26 accounts · 1 year
Total assets $12.7B
Total liabilities $6.0B
Shareholders equity $6.7B
Account 2025 Trend
Assets
Cash and Cash Equivalents —
Accounts Receivable —
Inventory —
Other Current Assets —
Total Current Assets —
Property,Plant and Equipment —
Goodwill —
Intangible Assets —
Long Term Investments —
Other Noncurrent Assets —
Total Assets —
Liabilities
Accounts Payable —
Accrued Liabilities —
Deferred Revenue —
Current Portion of Long Term Debt —
Total Current Liabilities —
Long Term Debt —
Other Noncurrent Liabilities —
Total Liabilities —
Equity
Preferred Stock —
Common Stock —
Additional Paid In Capital —
Retained Earnings —
Accumulated Other Comprehensive Income —
Total Stockholders Equity —
Total Liabilitiesand Equity —

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year
Ratio 2025
Profitability
Gross margin +52.4%
Operating margin +21.3%
Net margin +18.8%
FCF margin +16.6%
Growth
Revenue CAGR (3y) +0.5%
Returns
ROE +19.3%
ROA +10.2%
ROIC +16.2%
Liquidity
Current ratio 1.96x
Quick ratio 1.40x
Leverage
D/E 0.89x
Interest coverage 13.21x
Efficiency
Asset turnover 0.55x
Cash conversion cycle +128d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 212d old · FY2025
Market cap $32.9B
P/E 25.26x
P/S 4.74x
P/B 4.88x
EV $34.5B
EV/EBITDA —
FCF yield +3.5%
Dividend yield +0.9%

Notes

Your annotations

Not watched
Saving notes adds A to your watchlist.